HPV test to prevent cervical cancer
- INTIMACY: the test you do to yourself.
- COMFORT: The test you take whenever you want, without pain or discomfort.
- FLEXIBILITY: the test you take when it suits you, without queues or waiting.
HPV test to prevent cervical cancer
99,00 €
Detect if you need treatment early
The main cause of cervical cancer is genital infection with the human papillomavirus.
To date, 40 strains of the virus are known to infect the anogenital tract and are classified into different categories depending on the risk of producing malignant lesions.
Performing a papillomavirus test and distinguishing between the presence of low- and high-risk viruses, as well as the persistence of the infection, allows us to identify patients at high risk of developing cervical cancer and to determine a prognosis and follow-up of the case.
Medical societies recommend the use of the HPV test as a priority for the prevention of cervical cancer.
Strains analyzed in the HPV test
16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68
RESULTS
The HPV test offers more sensitivity than cytology
Why monitor for human papillomavirus?
- It is the most common sexually transmitted infection.
- 80% of women will become infected at some point in their lives.
- It causes 99% of cervical cancer cases.
- The mortality rate for cervical cancer is 50%.
Why use our Evalyn Brush device?
- It is the only self-tapping device that offers a flexible brush for greater comfort.
- It offers a system that guarantees correct sample collection in 99.69% of cases.
- Its design is ergonomic to offer maximum comfort.
- It is the device chosen in national cervical cancer screening programs.
Recommended by medical societies
The WHO and the ACS consider self-sampling devices to be very useful in reducing the prevalence of cervical cancer.
How to perform the test?
-
0
HPV strains included
-
0
% more sensitivity
-
0
countries use Evalyn Brush
— Our commitment
Quality and technology
-
We only analyze variants with solid scientific evidence
Our expert panel selects and reviews variants with solid scientific evidence based on scientific literature and medical guidelines.
-
Quality Assurance
The laboratory where samples are processed and analyzed holds ISO 15189 and 9001 certifications.
-
We use the best technology available
We use the PMDA (Precision Medicine Diversity Array) platform by Applied BioSystems, which enables the analysis of over 850,000 genetic markers in your DNA with a quality rate over 99%. It is the most comprehensive platform on the market, designed to cover all relevant genetic variants related to your health. This platform includes genetic variants from all ancestral populations and also provides analysis of specific mitochondrial DNA and Y chromosome markers, allowing for a deeper and more accurate understanding of your ancestral origins.
FAQS
Do you have questions about the HPV test?
Other people have asked this:
How will I receive my test once I have purchased it?
You will receive your package within 1-3 business days. You will receive the kit, bags, and materials needed to return the sample to the lab, as well as a sample collection instruction sheet and a request form.
How should I send the sample?
Follow the instructions received with the kit. Place the sample and the request form inside the courier’s return envelope. To request sample collection, simply contact us through our communication channels (phone, WhatsApp, or email) and specify the day and time slot, as well as the address at which you would like the delivery person to collect the sample. You can also take the package yourself to any NACEX branch. Once the sample arrives at our laboratory, you will receive an automatic email confirming receipt.
When should the sample be sent?
Once extracted, the sample is stable at room temperature for days or months, depending on the kit used. We recommend sending the sample to our laboratory as soon as possible. Once in the laboratory, the samples undergo quality control to ensure they meet the minimum requirements necessary to begin analysis.
Do you ship internationally?
Yes, we ship to several countries. During the checkout process, additional shipping costs will be automatically calculated, if applicable, before confirming payment.
Is this a study to diagnose cancer?
No, it is a screening test capable of detecting genetic variants that confer a higher risk than the general population of developing various types of cancer throughout life.
Does this test help determine the risk of developing any type of cancer?
Cancer is a multifactorial disease in which genetics plays a fundamental role, but other environmental factors are key to the development of the disease. However, although all cancers are genetic (due to the presence of a genetic mutation in cells of a specific tissue), this does not mean they are hereditary. These types of cancer are sporadic and are associated with environmental factors such as smoking, excessive unprotected sun exposure, or poor nutrition, among other factors. Furthermore, it is known that approximately 5-10% of all cancers have a hereditary origin, meaning they are due to genetic variants present in all of an individual’s cells that we have inherited from our parents or that we developed in the very early stages of embryonic development. These are the types of cancers evaluated in AboutMe – Cancer Prevention Test.
I have had cancer in the past, should I take this test?
Taking the test can help you understand whether your cancer is hereditary or not. However, in this case, we recommend that you first schedule a consultation with our expert cancer geneticists so they can assess the suitability of a more comprehensive and personalized study.
I have one or more family members who have had cancer. Should I take this test?
In these cases, the ideal protocol is to first perform a genetic study on family members who have suffered from cancer. This will allow us to determine whether the cancer they have suffered is hereditary or sporadic. However, if this is not possible, you can still benefit from a genetic test capable of detecting genetic variants that confer a higher risk of developing various types of cancer compared to the general population. We recommend that you consult with one of our cancer geneticists beforehand so they can assess the suitability of performing this or another type of genetic study.
Why is my risk of developing cancer not zero if I don’t have genetic variants?
If we do not present genetic variants, we can greatly reduce the risk of developing various types of hereditary cancer. However, we cannot rule out the development of sporadic cancer, which any individual in the general population could develop. For example, the lifetime risk of women in the general population developing breast cancer is approximately 12%. However, women with genetic variants in the BRCA1 or BRCA2 genes have an increased risk of 72% and 69%, respectively. Thus, if no genetic variants are found in our AboutMe Cancer Prevention Test, it would help determine whether your risk of developing breast cancer is similar to that of the general population.
— Do you have any more questions?
Ask us your questions
Call us at +34 93 115 99 50, send us a message on WhatsApp, or fill out the form below: